Our data, in addition to previous evidence allow a better breast patients stratification based on homogeneous prognosis, in fact while the high expression of ENO1 and MMPs are associated with a worse prognosis, the expression of MBP-1 is associated with a decrease in MMPs activity, a less aggressive biological features of the tumor and better prognosis. The gene discussed is ENO1; the disease is neoplasm.